Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC), a type of liver cancer, remains a treatment challenge due to late detection and resistance to currently approved drugs. It takes 15–20 years for a single new drug to become FDA approved. The purpose of this study was to expedite identification of novel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: Regan-Fendt, Kelly, Li, Ding, Reyes, Ryan, Yu, Lianbo, Wani, Nissar A., Hu, Peng, Jacob, Samson T., Ghoshal, Kalpana, Payne, Philip R.O., Motiwala, Tasneem
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598246/
https://ncbi.nlm.nih.gov/pubmed/32977582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102730
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items